New Journey Health Technology Group Co.,LTD (SHE:002219)

China flag China · Delayed Price · Currency is CNY
2.170
+0.030 (1.40%)
May 29, 2026, 3:04 PM CST
Market Cap7.47B -1.7%
Revenue (ttm)2.98B -18.3%
Net Income25.76M -77.0%
EPS0.01 -77.2%
Shares Out 3.44B
PE Ratio278.10
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume62,261,598
Open2.190
Previous Close2.140
Day's Range2.140 - 2.190
52-Week Range2.030 - 2.970
Beta0.35
AnalystsHold
Price Target15.84 (+629.95%)
Earnings DateAug 25, 2026

About SHE:002219

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Schisandra tablets, Maiping tablets, Prosta Antong tablets, Gongzhongning capsules, Wuhu San, Wei Funing capsules, and other pro... [Read more]

Sector Healthcare
Founded 2001
Employees 8,843
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002219
Full Company Profile

Financial Performance

In 2025, SHE:002219's revenue was 3.05 billion, a decrease of -19.64% compared to the previous year's 3.80 billion. Earnings were 30.94 million, a decrease of -73.04%.

Financial Statements